CRISPR cuts gene from head and neck cancers through direct injectionÑ50% of tumors eliminated in animal models
Researchers from Tel Aviv University utilized CRISPR to cut a single gene from cancer cells of head and neck tumorsÑand successfully eliminated 50% of the tumors in model animals.
Diabetes drug could help cancer patients make better recovery
A common type of diabetes medication could help cancer patients make a better long-term recovery, according to new research from the University of East Anglia.
Minimally invasive prostate cancer treatment shows success in first patient
Bill Faulkner had long approached prostate cancer testing with skepticism. For almost a decade, the 73-year-old had avoided the prostate-specific antigen test because of concerns about over-diagnosis; over-treatment; and, most of all, the potentially life-altering side effects of invasive surgical treatments.
New drug shows promise in treating childhood bone cancer
A new drug that works against the main types of primary bone cancer has been developed by researchers at the University of East Anglia and University of Sheffield.
Certain genetic alterations may contribute to primary resistance of certain cancers to KRAS G12C inhibitors
The KRAS G12C mutation is found in approximately 3% of all colorectal cancer cases and 1% to 2% of pancreatic adenocarcinoma cases, according to Hao Xie, MD, PhD, a medical oncologist at Mayo Clinic Comprehensive Cancer Center.
Common malaria drug repurposed to fight cancer
Can a drug that’s used to treat malaria be repurposed to fight cancer? Researchers at The University of Texas at El Paso have secured a patent for the anti-malarial drug pyronaridine to do just that. Pyronaridine has been used to treat the mosquito-borne infectious disease for over 30 years.
Genetic testing offers hope for targeted childhood cancer therapies
New research has looked into a comprehensive and structured approach to genetic testing, matching children and young people with cancer to targeted treatments.
Study finds new potential for prostate cancer immunotherapy
A new study by University of Arizona Health Sciences researchers found that an immunotherapy previously shown to be ineffective against prostate cancer may have therapeutic potential when combined with a synergistic treatment approach. The paper was published in the journal Cancer Immunology Research.
Inhibiting GATA6 protein may be key to winning the fight against colon cancer
Northwestern Medicine scientists have discovered that inhibiting the GATA6 protein in mouse models of colon cancer reduced tumor growth and improved survival, underscoring the potential of a new therapeutic target for colon cancer, according to a recent study published in Science Advances.
Study indicates that exercise can help colon cancer survivors live as long as matched individuals
Physical activity may help colon cancer survivors achieve long-term survival rates similar to those of people in the general population, according to a study published in Cancer.
A protein from tiny tardigrades may help cancer patients tolerate radiation therapy
About 60% of all cancer patients in the United States receive radiation therapy as part of their treatment. However, this radiation can have severe side effects that often end up being too difficult for patients to tolerate.
Cancerous breast tissue glows in new AI-enhanced MRI images
Imaging technology developed and refined at the University of Waterloo promises better detection and treatment of breast cancer by more accurately pinpointing cancerous tissue.
